Crescent Biopharma, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $7.1M | $42.4M | $40.0M |
| FY2017 | $8.9M | $128.6M | $123.9M |
| FY2018 | $9.4M | $214.8M | $209.9M |
| FY2019 | $13.8M | $168.0M | $158.2M |
| FY2020 | $14.6M | $142.8M | $137.0M |
| FY2021 | $12.7M | $94.3M | $90.3M |
| FY2022 | $8.9M | $51.8M | $47.9M |
| FY2023 | $6.9M | $45.3M | $41.8M |
| FY2024 | $47.1M | $35.6M | $0 |
| FY2025 | $37.3M | $240.3M | $213.2M |